Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-13

Clinical Trial Update: An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting efficacy and safety results for infliximab in rheumatoid arthritis. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infliximab (infliximab)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED | Results posted: 2013-09-13